NDC 0338-7112 - TISSEEL Fibrin Sealant
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0338-7112
- Package NDCs from labels
- 0338-7112-01, 0338-7112-02, 0338-7112-05
- Manufacturer
- Baxter Healthcare Corporation
- Effective date
- 2025-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| TISSEEL Fibrin Sealant - Baxter Healthcare Corporation | Baxter Healthcare Corporation | 2025-09-30 | PLASMA DERIVATIVE |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 0338-7112-01 | TISSEELFibrin Sealant | 1 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 1 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-01 | TISSEELFibrin Sealant | 1 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 1 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-02 | TISSEELFibrin Sealant | 2 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 2 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-02 | TISSEELFibrin Sealant | 2 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 2 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-05 | TISSEELFibrin Sealant | 5 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 5 mL | 86.5 mg in 1mL | 9 |
| 0338-7112-05 | TISSEELFibrin Sealant | 5 mL in 1 VIAL, GLASS | POWDER, FOR SOLUTION | 5 mL | 86.5 mg in 1mL | 9 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 0338-7112 | TISSEEL FIBRIN SEALANT (FIBRINOGEN HUMAN, HUMAN THROMBIN) KIT TISSEEL FIBRIN SEALANT (FIBRINOGEN HUMAN, HUMAN THROMBIN) SOLUTION [BAXTER HEALTHCARE CORPORATION] | 8 | Unmatched | 20240802_b3f69e25-1b87-4507-81fa-582ea084673d.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| N-10 | SODIUM CHLORIDE, OYSTER SHELL CALCIUM CARBONATE, CRUDE, SEPIA OFFICINALIS JUICE, IODINE, LYCOPODIUM CLAVATUM WHOLE, AND BOS TAURUS PITUITARY GLAND, POSTERIOR | DNA Labs, Inc. | 264d8093-70f3-43a5-bfc4-b719bb3e45e6 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-16 | MGO ENERGIZER | DNA Labs, Inc. | 8292b900-86c1-47ea-81da-b587439c7664 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-21 | CALCIUM FLUORIDE, SILICON DIOXIDE, EUPHRASIA STRICTA, RUTA GRAVEOLENS WHOLE, GELSEMIUM SEMPERVIRENS WHOLE, PHYSOSTIGMA VENENOSUM WHOLE, ANEMONE PULSATILLA, SODIUM CHLORIDE, AND SUS SCROFA EYE | DNA Labs, Inc. | 89967941-c4ee-4598-a66d-8a93d69a4d65 | 2025-01-09 | Warnings | 451W47IQ8X |
| N-14 | FUCUS VESICULOSUS, SODIUM CHLORIDE, LYCOPUS VIRGINICUS, SPONGIA OFFICINALIS SKELETON, ROASTED, POTASSIUM IODIDE, CALCIUM IODIDE, THYROID, UNSPECIFIED, BOS TAURUS ADRENAL GLAND, BOS TAURUS PITUITARY GLAND, POSTERIOR, BOS TAURUS THYMUS, AND SUS SCROFA SPLEEN | DNA Labs, Inc. | 3d64739c-5d61-4e88-8612-d5f6994f1c3c | 2025-01-09 | Warnings | 451W47IQ8X |
| N-24 | METABOLIN | DNA Labs, Inc. | 559fca2b-1093-4bdf-be70-c453f87002c3 | 2025-01-09 | Warnings | 451W47IQ8X |
| T-27 | WATER | DNA Labs, Inc. | f0e9afd7-64a4-4b85-9c5f-4bf07ba4b481 | 2025-01-09 | Warnings | 059QF0KO0R |
| Sterile Water | STERILE WATER FOR INJECTION | Medefil, Inc. | 99e99a50-82d5-aff6-e053-2a95a90a8c56 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| BACTERIOSTATIC WATER | BACTERIOSTATIC WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b0ef9b-600a-40dc-e053-2a95a90aa07e | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| 0.9% SODIUM CHLORIDE | 0.9% SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 8dfb05c0-77e8-2fa1-e053-2a95a90a3d33 | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| STERILE WATER | STERILE WATER | HF Acquisition Co LLC, DBA HealthFirst | 99b1cb12-0b2d-0c0f-e053-2a95a90ac3b6 | 2025-01-08 | Warnings, Adverse reactions | 059QF0KO0R |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 998a2a47-5c79-2efd-e053-2995a90a8fac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| SODIUM CHLORIDE | SODIUM CHLORIDE | HF Acquisition Co LLC, DBA HealthFirst | 7da788fc-3481-527f-e053-2a91aa0af6ac | 2025-01-08 | Adverse reactions | 451W47IQ8X |
| Emetrol Powder Non-Drowsy | SODIUM CITRATE DIHYDRATE | WellSpring Pharmaceutical Corporation | 9d8d2ee7-9db7-4be7-8c73-511eb2e32459 | 2025-01-08 | Warnings | B22547B95K |
| Dextrose and Sodium Chloride | DEXTROSE MONOHYDRATE AND SODIUM CHLORIDE | BECTON DICKINSON AND COMPANY | c1d0f42e-3494-4217-8f86-e9f34d930e82 | 2025-01-07 | Warnings, Adverse reactions | 451W47IQ8X |
| TURMERICFaceCream | NIACINAMIDE | Shengnan (Guangzhou) Cosmetics Co., LTD | 2b0652be-a216-d66b-e063-6394a90a0b28 | 2025-01-06 | Warnings | 25X51I8RD4 |
| Milia Remover Treatment | MILIA REMOVER | Shenzhen Xinxin Yunhai Technology Co., Ltd. | 0a8c7bdb-19f4-54c9-e063-6394a90ac5f5 | 2025-01-04 | Warnings | 25X51I8RD4 |
| Dr.Jucre Rebirth BB | TITANIUM DIOXIDE, OCTINOXATE, ZINC OXIDE, NIACINAMIDE, ADENOSINE | NATURECELL CO., LTD. | 2ab403df-29b3-75af-e063-6394a90a6ca4 | 2025-01-02 | Warnings | 25X51I8RD4 |
| Dr.Jucre Rebirth Eye | NIACINAMIDE | NATURECELL CO., LTD. | 2ab43971-57b4-aa2c-e063-6294a90a8f7b | 2025-01-02 | Warnings | 25X51I8RD4 |
| Dr.Jucre Rebirth Booster | NIACINAMIDE | NATURECELL CO., LTD. | 2ab42408-1323-9d79-e063-6394a90a434b | 2025-01-02 | Warnings | 25X51I8RD4 |
| Dr.Jucre Rebirth | NIACINAMIDE, ADENOSINE | NATURECELL CO., LTD. | 2ab449f5-02eb-b075-e063-6394a90a9b50 | 2025-01-02 | Warnings | 25X51I8RD4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.